Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies

Eur Heart J. 2020 Apr 21;41(16):1602-1603. doi: 10.1093/eurheartj/ehaa214.

Authors

Ramón C Hermida¹, Juan J Crespo^{1

2}, Manuel Domínguez-Sardiña²

Affiliations

¹ Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Informatio n and Communication Technologies (AtlantTIC), University of Vigo, Campus Universitario, Vigo 36310, Spain.
² Estructura de Xestión Integrada de Vigo, Servicio Galego de Saúde (SERGAS), Vigo 36214, Spain.

PMID: 32298422
DOI: 10.1093/eurheartj/ehaa214

No abstract available

Publication types

Comment

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors / adverse effects
Cardiovascular Diseases* / prevention & control
Chronotherapy
Eating
Heart Disease Risk Factors
Humans
Hypertension* / drug therapy
Risk Factors

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors